Log In
Print this Print this

Selincro, nalmefene

  Manage Alerts
Collapse Summary General Information
Company Biotie Therapies Corp.
DescriptionOpioid receptor antagonist
Molecular Target Opioid receptor (OPR)
Mechanism of ActionOpioid receptor antagonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationAddiction
Indication DetailsTreat alcohol addiction; Treat pathological gambling; Treat smoking cessation
Regulatory Designation
Partner H. Lundbeck A/S; Otsuka Pharmaceutical Co. Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments





 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today